Feminine Care net sales decreased $7.9 million, or 9.6%, as compared to the prior year period, driven by volume declines in all lines, except for Sport Tampons, where increased promotional support helped drive higher volumes in the quarter. Feminine Care segment profit increased $2.7 million, or 56.3% as compared to the prior year period, driven by favorable cost mix and lower A&P and SG&A expense.
In order to best position the company for growth and value creation, the company is exploring strategic alternatives for the Feminine Care and Infant Care businesses, including the potential sale of one or both businesses. According to the company, there can be no assurance that the company's exploration of strategic options will result in any transaction or other action by the company, or the timing thereof. The company does not intend to comment on or provide updates regarding these matters unless and until it determines that further disclosure is appropriate or required based on then known or material facts and circumstances.